文献速递慢性肾脏病

可预防的医院获得性并发症与CKD患者不良结局相关

Adverse Outcomes Associated with Preventable Complications in Hospitalized Patients with CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-04-27

该研究基于加拿大阿尔伯塔省2003年4月至2008年3月所有成人住院数据,按肾功能和可预防医院获得性并发症(HAC)发生情况分析。CKD定义为eGFR<60 ml/min per 1.73 m2和/或白蛋白肌酐比>3-30 mg/mmol持续超过3个月。结果显示,CKD患者发生可预防HAC与住院期间死亡率、住院时间延长和再入院风险增加相关,尤其CKD合并HAC患者死亡风险显著升高。

要点

  • CKD患者中9.8%发生至少一种可预防HAC。
  • CKD合并可预防HAC的住院死亡率调整OR为4.67(95%CI 4.17-5.22)。
  • 可预防HAC使中位住院时间增加9.86天(95%CI 9.25-10.48)。

核心结论

  • 可预防HAC与更高的死亡率、住院时间延长和再入院风险相关,尤其在CKD患者中。

研究设计与样本

  • 回顾性队列研究,纳入2003年4月至2008年3月加拿大阿尔伯塔省所有成人住院(n=536,549),按肾功能和可预防HAC发生情况分组,采用回归模型分析HAC与结局的关联。

主要发现

  • 536,549例住院中,8.5%(n=45,733)有CKD,9.8%的CKD患者发生至少一种可预防HAC。
  • 发生可预防HAC的患者住院期间死亡比例为17.7%,出院至90天死亡比例为6.8%。
  • 在CKD患者中,与无HAC相比,发生至少一种可预防HAC的住院期间死亡调整OR为4.67(95%CI 4.17-5.22),出院至90天死亡调整OR为1.08(95%CI 0.94-1.25)。
  • 发生至少一种可预防HAC的中位住院时间增加9.86天(95%CI 9.25-10.48),再入院调整OR为1.24(95%CI 1.15-1.34)。
  • 以无CKD且无HAC为参照,CKD无HAC、无CKD有HAC、CKD有HAC的住院期间死亡调整OR分别为2.22(95%CI 1.69-2.94)、5.26(95%CI 4.98-5.55)、9.56(95%CI 7.23-12.56)。

关键数值与推荐

  • CKD定义:eGFR<60 ml/min per 1.73 m2和/或白蛋白肌酐比>3-30 mg/mmol持续超过3个月(入院前365至90天时间窗内)。

临床怎么用

  • 对CKD住院患者应优先采取针对性策略减少可预防HAC,以降低死亡、住院时间延长和再入院风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: and objectives Patients with CKD are at risk of hospital-acquired complications (HACs). We sought to determine the association of preventable HACs with mortality, length of stay (LOS), and readmission. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: All adults hospitalized from April of 2003 to March of 2008 in Alberta were characterized by kidney function and occurrence of preventable HACs. CKD was defined by eGFR<60 ml/min per 1.73 m2 and/or albumin-to-creatinine ratio >3-30 mg/mmol for >3 months in the time frame from 365 to 90 days before admission. Regression models examined the association of HACs with outcomes. RESULTS: Of 536,549 hospitalizations, 8.5% (n=45,733) had CKD and 9.8% of patients with CKD had one or more potentially preventable HAC. In patients with potentially preventable HACs, proportions of death within index hospitalization and from discharge to 90 days were 17.7% and 6.8%, respectively. In patients with CKD, comparing with those hospitalizations without potentially preventable HACs, the adjusted odds ratio (OR) of mortality during index hospitalization and from hospital discharge to 90 days in patients with one or more preventable HAC was 4.67 (95% confidence interval [95% CI], 4.17 to 5.22) and 1.08 (95% CI, 0.94 to 1.25), respectively. Median incremental LOS in patients with one or more preventable HAC was 9.86 days (95% CI, 9.25 to 10.48). The OR for readmission with preventable HAC was 1.24 (95% CI, 1.15 to 1.34). In a cohort with and without CKD, the adjusted ORs of mortality during index hospitalization in patients with CKD and no preventable HACs, patients without CKD and with preventable HACs, and patients with CKD and preventable HACs were 2.22 (95% CI, 1.69 to 2.94), 5.26 (95% CI, 4.98 to 5.55), and 9.56 (95% CI, 7.23 to 12.56), respectively (referenced to patients without CKD or preventable HACs). CONCLUSIONS: Preventable HACs are associated with higher mortality, incremental LOS, and greater risk of readmission, especially in people with CKD. Targeted strategies to reduce complications should be a high priority.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Bohlouli B, Jackson TJ, Tonelli M, et al. Adverse Outcomes Associated with Preventable Complications in Hospitalized Patients with CKD. Clin J Am Soc Nephrol. 2017. PMID: 28450414. doi:10.2215/CJN.09410916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。